Rachel Humphrey: What cancer immunologists are doing about COVID-19

Overview

What are physicians and scientists seeing in their COVID-19-infected patients and in their own personal scientific explorations? What are the ongoing hypotheses that drive the emerging clinical studies, and what can we say about the rapid evolution of medicine, in light of their ongoing work? Rachel Humphrey, shares her insights.

Rachel is a medical oncologist, who is currently serving as Head of Research and Development for TIO Bioventures. The webinar is moderated by Miriam Merad, Vice-President of the IUIS.

Speakers

Miriam Merad
Moderator

Miriam Merad is Vice-President of the IUIS.

Webinar Details

Categories: COVID-19

More Webinars

Kate Schroder: Inflammasome signalling

Yasmine Belkaid: Microbiome control of host immunity

Wolf H. Fridman: Shaping of anti-tumor immunity in the tumor microenvironment

Greg Delgoffe: Metabolic control of T cell differentiation during immune responses to cancer

Shane Crotty: Adaptive Immunity and Immune Memory to SARS-CoV-2 after COVID-19

Akiko Iwasaki: Immune responses to SARS-CoV-2

Kondwani Jambo: The unusual COVID-19 pandemic: the African story

Lynn Morris: HIV prevention: antibodies and vaccine development

Andrea Cossarizza: Immunopathology of COVID-19: lessons from pregnancy and from ageing